• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

EU drug regulator records 415 cases of possible rare blood clotting

firstwordpharmaJune 18, 2021

Tag: AstraZeneca , Johnson & Johnson , COVID-19 , Vaccine

The EU drug regulator said on Thursday it has received reports of 415 possible cases of thrombosis with thrombocytopenia syndrome in the European Economic Area (EEA), out of over 50 million people who have gotten AstraZeneca and Johnson & Johnson's COVID-19 vaccines, as reported in Fidelity.

EU drug regulator records 415 cases of possible rare blood clotting

Specifically, there have been 10 possible cases among just under 6 million people who received Johnson & Johnson's shot in the EEA, and 405 cases among 45 million who received AstraZeneca's shot, stated Georgy Genov, head of pharmacovigilance at the European Medicines Agency.


Previous:Alzamend Neuro Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-allotment Option for Gross Proceeds of $14.4 Million

Next:U.S. Buys 200 Million Extra Moderna Vaccine Doses, as Possible Booster Shots

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

EU drug regulator records 415 cases of possible rare blood clotting | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Varicella Vaccine,Live (Vial)

Varicella Vaccine,Live (Vial)
Poultry Vaccine Series

Poultry Vaccine Series
Varicella Vaccine,Live (Pre-filled syringe)

Varicella Vaccine,Live (Pre-filled syringe)
Recombinant B-Subunit/Whole Cell Cholera Vaccine(Enteric-coated Capsule)

Recombinant B-Subunit/Whole Cell Cholera Vaccine(Enteric-coated Capsule)
Hepatitis A (Live) Vaccine, Freeze-Dried

Hepatitis A (Live) Vaccine, Freeze-Dried
Real Time Multiplex RT-PCR Kit (for COVID-19)

Real Time Multiplex RT-PCR Kit (for COVID-19)
Swine Vaccine Series

Swine Vaccine Series
500ml pp vaccine bottle manufacturer

500ml pp vaccine bottle manufacturer
Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production

Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production
Human Vaccine

Human Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service